Indicative value of pathological classification of duodenal papillary adenomas in clinical diagnosis and treatment

Surg Endosc. 2022 Jul;36(7):5183-5197. doi: 10.1007/s00464-021-08894-0. Epub 2022 Mar 14.

Abstract

Objectives: The relationship between the pathological classification and recurrence of duodenal papillary adenomas (DPAs) has not been elucidated. We studied the clinicopathological characteristics of DPAs with different pathological types and conducted long-term follow-up to explore its prognosis and identify methods for appropriate clinical management of DPAs.

Methods: In total, 95 DPA cases confirmed by postoperative pathology were enrolled, of which 58 underwent endoscopic papillectomy (EP) and 37 underwent pancreatoduodenectomy (PD). The cases were classified into three anatomical and two histomorphological types according to the histopathology and location of endoscopic features. We analyzed the clinicopathological characteristics of DPAs with different pathological types and investigated the factors associated with recurrence in the EP subgroup.

Results: Although EP was associated with fewer adverse events, the complete resection rate was significantly lower (72.4% vs. 100.0%, p < 0.001) and the recurrence rate significantly higher than with PD (16.3% vs. 0.0%, p < 0.001). Among eight EP cases with recurrence, six had intra-DPA (75%). A positive resection margin (HR 23.67, 95% CI 6.42-87.27; p < 0.001) and MUC2-negative status (HR 3.47, 95% CI 1.16-10.40; p = 0.026) were independent risk factors for recurrence after EP.

Conclusion: We identified different pathological types within DPAs, which presented varying clinicopathological features. The majority of peri-DPAs and mixed-DPAs were of the intestinal type histologically and EP is the primary recommendation. However, intra-DPA was mainly of the pancreaticobiliary type, which tends to get positive resection margins; thus, surgical resection is more suitable.

Keywords: Adenoma; Classification; Diagnosis; Treatment; Tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma* / pathology
  • Adenoma* / surgery
  • Ampulla of Vater* / surgery
  • Common Bile Duct Neoplasms* / surgery
  • Humans
  • Margins of Excision
  • Neoplasm Recurrence, Local / surgery
  • Pancreaticoduodenectomy
  • Retrospective Studies
  • Treatment Outcome